|
Chang, Y P; Maier-Redelsperger, M; Smith, K D et al. (1997) The relative importance of the X-linked FCP locus and beta-globin haplotypes in determining haemoglobin F levels: a study of SS patients homozygous for beta S haplotypes. Br J Haematol 96:806-14
|
|
Bridges, K R; Barabino, G D; Brugnara, C et al. (1996) A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood 88:4701-10
|
|
Chang, Y C; Smith, K D; Moore, R D et al. (1995) An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age. Blood 85:1111-7
|
|
Collins, A F; Pearson, H A; Giardina, P et al. (1995) Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial. Blood 85:43-9
|
|
Chang, Y P; Smith, K D; Dover, G J (1994) Dinucleotide repeat polymorphisms at the DXS85, DXS16 and DXS43 loci. Hum Mol Genet 3:1029
|
|
Stamatoyannopoulos, G; Blau, C A; Nakamoto, B et al. (1994) Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood 84:3198-204
|
|
Dover, G J; Brusilow, S; Charache, S (1994) Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 84:339-43
|
|
McDonagh, K T; Dover, G J; Donahue, R E et al. (1992) Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate. Exp Hematol 20:1156-64
|
|
Dover, G J; Smith, K D; Chang, Y C et al. (1992) Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 80:816-24
|
|
Fujimori, Y; Ogawa, M; Clark, S C et al. (1990) Serum-free culture of enriched hematopoietic progenitors reflects physiologic levels of fetal hemoglobin biosynthesis. Blood 75:1718-22
|
Showing the most recent 10 out of 20 publications
